LLY
Eli Lilly and Company
October 20, 2026 · market open
- Rarity
- 1.36
- Peak move
- +5.73%
- Float cap
- $1.05T
Still running — rarity and peak move can only rise from here.
Eli Lilly and Company is a pharmaceutical company that discovers, develops, manufactures, and markets human medicines sold in roughly 90 countries. Its products span cardiometabolic health (Mounjaro, Zepbound, Jardiance, Humalog, Trulicity), oncology (Verzenio, Cyramza, Jaypirca), immunology (Taltz, Olumiant), and neuroscience (Emgality, Kisunla). Customers include wholesale distributors, hospitals, pharmacies, and government and commercial insurers.
Where do you see this going?
no votes yetVote to see the split.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNothing found.We searched SEC filings, the newswires and the open web across the three days around this move and found no public information that explains it.